X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (45) 45
female (44) 44
oncology (41) 41
breast cancer (39) 39
index medicus (37) 37
middle aged (26) 26
breast neoplasms - drug therapy (25) 25
cancer (24) 24
chemotherapy (24) 24
adult (23) 23
aged (21) 21
breast neoplasms - pathology (19) 19
breast neoplasms - genetics (15) 15
therapy (15) 15
chemotherapy, adjuvant (14) 14
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
clinical trials (13) 13
disease-free survival (12) 12
tumors (12) 12
research (11) 11
survival (11) 11
analysis (10) 10
prognosis (10) 10
treatment outcome (10) 10
antineoplastic agents, hormonal - therapeutic use (9) 9
cancer therapies (9) 9
care and treatment (9) 9
expression (9) 9
genetic aspects (9) 9
hematology, oncology and palliative medicine (9) 9
adjuvant chemotherapy (8) 8
breast neoplasms - mortality (8) 8
estrogen (8) 8
health aspects (8) 8
life sciences (8) 8
metastasis (8) 8
mutation (8) 8
neoplasm metastasis (8) 8
studies (8) 8
tamoxifen (8) 8
trastuzumab (8) 8
women (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
medicine & public health (7) 7
neoadjuvant chemotherapy (7) 7
neoplasm staging (7) 7
tamoxifen - therapeutic use (7) 7
adjuvant treatment (6) 6
aged, 80 and over (6) 6
article (6) 6
breast neoplasms (6) 6
breast neoplasms - metabolism (6) 6
breast neoplasms - surgery (6) 6
drug therapy (6) 6
endocrine therapy (6) 6
erbb-2 protein (6) 6
medicine, general & internal (6) 6
metastases (6) 6
oncology, experimental (6) 6
pathological complete response (6) 6
patients (6) 6
postmenopausal women (6) 6
receptor, erbb-2 - metabolism (6) 6
tamoxifen - adverse effects (6) 6
antineoplastic agents, hormonal - adverse effects (5) 5
apoptosis (5) 5
aromatase inhibitors - adverse effects (5) 5
aromatase inhibitors - therapeutic use (5) 5
biopsy (5) 5
breast neoplasms - therapy (5) 5
docetaxel (5) 5
doxorubicin (5) 5
follow-up studies (5) 5
kaplan-meier estimate (5) 5
medical prognosis (5) 5
medicine (5) 5
neoadjuvant therapy (5) 5
predictive value of tests (5) 5
progesterone (5) 5
receptor, erbb-2 - genetics (5) 5
receptors, estrogen - analysis (5) 5
receptors, estrogen - metabolism (5) 5
receptors, progesterone - metabolism (5) 5
research article (5) 5
surgery (5) 5
survival analysis (5) 5
[ sdv.can ] life sciences [q-bio]/cancer (4) 4
abridged index medicus (4) 4
bioinformatics (4) 4
breast (4) 4
breast neoplasms - diagnosis (4) 4
cell biology (4) 4
cyclophosphamide (4) 4
cyclophosphamide - administration & dosage (4) 4
development and progression (4) 4
drug administration schedule (4) 4
epirubicin - administration & dosage (4) 4
fluorouracil - administration & dosage (4) 4
follow-up (4) 4
further section · weitere sektionen (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 5, pp. 436 - 446
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2014, Volume 371, Issue 2, pp. 107 - 118
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2018, Volume 379, Issue 2, pp. 122 - 137
Journal Article
Journal Article
by Pivot, Xavier and Romieu, Gilles and Debled, Marc and Pierga, Jean-Yves and Kerbrat, Pierre and Bachelot, Thomas and Lortholary, Alain and Espié, Marc and Fumoleau, Pierre and Serin, Daniel and Jacquin, Jean-Philippe and Jouannaud, Christelle and Rios, Maria and Abadie-Lacourtoisie, Sophie and Venat-Bouvet, Laurence and Cany, Laurent and Catala, Stéphanie and Khayat, David and Gambotti, Laetitia and Pauporté, Iris and Faure-Mercier, Celine and Paget-Bailly, Sophie and Henriques, Julie and Grouin, Jean Marie and Piprot, C and Cals, L and Chaigneau, L and Demarchi, F and N'Guyen, T and Stein, U and Villanueva, C and Bréau, JL and Chouahnia, AK and Saintigny, P and Boué, F and deSaint-Hilaire, P and Guimont, I and Grossat, N and Valenza, B and Lévy, E and Médioni, J and Delbaldo, C and Grenier, J and Pouessel, D and Lavau-Denès, S and Falandry, C and Fournel-Fédérico, C and Freyer, G and Tartas, S and Trillet-Lenoir, V and Bons, F and Auclerc, G and Chièze, S and Raban, N and Tournigand, C and Trager-Maury, S and Bousquet, G and Cuvier, C and Giacchetti, S and Hocini, A and LeMaignan, C and Misset, JL and Avenin, D and Beerblock, C and Gligorov, J and Rivera, P and Roché, H and Bougnoux, P and Hajjaji, N and Capitain, O and Delva, R and Maillart, P and Soulié, P and Bonnefoi, H and Durand, M and Madranges, N and Mauriac, L and Chollet, P and Dillies, AF and Durando, X and Ferrière, JP and Mouret-Reynier, C and Nabholtz, JM and Van Praagh, I and Cottu, P and Diéras, V and Durieux, A and Galotte, M and Girre, V and Henry, S and Iurisci, I and Jouve, M and Laurence, V and Mignot, L and Piperno-Neumann, S and Tresca, P and Coudert, B and Ferrant, E and Mayer, F and Vanneuville, AC and ... and PHARE Trial Investigators and PHARE trial investigators
The Lancet, ISSN 0140-6736, 06/2019, Volume 393, Issue 10191, pp. 2591 - 2598
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2014, Volume 32, Issue 26_suppl, pp. 61 - 61
61 Background: There is limited information on LRR rates in pts treated with NAC. Methods: 12 large NAC BC trials (11,955 pts) with pCR information and... 
Journal Article